Stock DNA
Pharmaceuticals & Biotechnology
CNY 5,666 Million (Micro Cap)
50.00
NA
0.00%
-0.64
9.12%
2.61
Revenue and Profits:
Net Sales:
324 Million
(Quarterly Results - Jun 2026)
Net Profit:
67 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
28.97%
0%
28.97%
6 Months
2.33%
0%
2.33%
1 Year
58.64%
0%
58.64%
2 Years
105.49%
0%
105.49%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Aidite (Qinhuangdao) Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
19.16%
EBIT Growth (5y)
17.73%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
73.65
Tax Ratio
9.48%
Dividend Payout Ratio
24.98%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
30.75%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
50
Industry P/E
Price to Book Value
4.58
EV to EBIT
45.21
EV to EBITDA
38.59
EV to Capital Employed
10.91
EV to Sales
7.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
24.14%
ROE (Latest)
9.12%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
324.30
257.50
25.94%
Operating Profit (PBDIT) excl Other Income
80.40
58.00
38.62%
Interest
0.00
0.40
-100.00%
Exceptional Items
4.40
0.20
2,100.00%
Consolidate Net Profit
66.80
38.70
72.61%
Operating Profit Margin (Excl OI)
208.80%
175.70%
3.31%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 25.94% vs -10.65% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 72.61% vs -29.64% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,027.30
883.60
16.26%
Operating Profit (PBDIT) excl Other Income
212.00
189.70
11.76%
Interest
3.50
2.80
25.00%
Exceptional Items
10.00
0.30
3,233.33%
Consolidate Net Profit
196.30
149.50
31.30%
Operating Profit Margin (Excl OI)
164.90%
181.50%
-1.66%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 16.26% vs 14.20% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 31.30% vs 1.56% in Dec 2024






